IBDEI0LO ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21857,0)
 ;;=I69.328^^89^1037^23
 ;;^UTILITY(U,$J,358.3,21857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21857,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,21857,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,21857,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,21858,0)
 ;;=E04.0^^89^1038^39
 ;;^UTILITY(U,$J,358.3,21858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21858,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,21858,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,21858,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,21859,0)
 ;;=E04.1^^89^1038^41
 ;;^UTILITY(U,$J,358.3,21859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21859,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,21859,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,21859,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,21860,0)
 ;;=E04.2^^89^1038^40
 ;;^UTILITY(U,$J,358.3,21860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21860,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,21860,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,21860,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,21861,0)
 ;;=E01.1^^89^1038^36
 ;;^UTILITY(U,$J,358.3,21861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21861,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,21861,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,21861,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,21862,0)
 ;;=E05.00^^89^1038^56
 ;;^UTILITY(U,$J,358.3,21862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21862,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,21862,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,21862,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,21863,0)
 ;;=E05.01^^89^1038^55
 ;;^UTILITY(U,$J,358.3,21863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21863,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,21863,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,21863,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,21864,0)
 ;;=E05.90^^89^1038^58
 ;;^UTILITY(U,$J,358.3,21864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21864,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,21864,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,21864,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,21865,0)
 ;;=E05.91^^89^1038^57
 ;;^UTILITY(U,$J,358.3,21865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21865,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,21865,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,21865,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,21866,0)
 ;;=E89.0^^89^1038^50
 ;;^UTILITY(U,$J,358.3,21866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21866,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,21866,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,21866,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,21867,0)
 ;;=E03.2^^89^1038^32
 ;;^UTILITY(U,$J,358.3,21867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21867,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,21867,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,21867,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,21868,0)
 ;;=E03.9^^89^1038^33
 ;;^UTILITY(U,$J,358.3,21868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21868,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,21868,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,21868,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,21869,0)
 ;;=E06.0^^89^1038^53
 ;;^UTILITY(U,$J,358.3,21869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21869,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,21869,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,21869,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,21870,0)
 ;;=E06.1^^89^1038^54
 ;;^UTILITY(U,$J,358.3,21870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21870,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,21870,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,21870,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,21871,0)
 ;;=C73.^^89^1038^37
 ;;^UTILITY(U,$J,358.3,21871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21871,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,21871,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,21871,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,21872,0)
 ;;=E10.21^^89^1038^8
 ;;^UTILITY(U,$J,358.3,21872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21872,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,21872,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,21872,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,21873,0)
 ;;=E10.9^^89^1038^12
 ;;^UTILITY(U,$J,358.3,21873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21873,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,21873,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,21873,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,21874,0)
 ;;=E11.21^^89^1038^17
 ;;^UTILITY(U,$J,358.3,21874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21874,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,21874,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,21874,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,21875,0)
 ;;=E11.39^^89^1038^18
 ;;^UTILITY(U,$J,358.3,21875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21875,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,21875,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,21875,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,21876,0)
 ;;=E11.43^^89^1038^15
 ;;^UTILITY(U,$J,358.3,21876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21876,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,21876,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,21876,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,21877,0)
 ;;=E11.59^^89^1038^13
 ;;^UTILITY(U,$J,358.3,21877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21877,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,21877,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,21877,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,21878,0)
 ;;=E11.618^^89^1038^14
 ;;^UTILITY(U,$J,358.3,21878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21878,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,21878,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,21878,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,21879,0)
 ;;=E11.621^^89^1038^16
 ;;^UTILITY(U,$J,358.3,21879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21879,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,21879,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,21879,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,21880,0)
 ;;=E11.622^^89^1038^20
 ;;^UTILITY(U,$J,358.3,21880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21880,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,21880,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,21880,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,21881,0)
 ;;=E11.65^^89^1038^19
 ;;^UTILITY(U,$J,358.3,21881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21881,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,21881,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,21881,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,21882,0)
 ;;=E11.9^^89^1038^21
 ;;^UTILITY(U,$J,358.3,21882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21882,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,21882,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,21882,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,21883,0)
 ;;=E13.9^^89^1038^22
 ;;^UTILITY(U,$J,358.3,21883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21883,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,21883,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,21883,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,21884,0)
 ;;=E16.2^^89^1038^29
 ;;^UTILITY(U,$J,358.3,21884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21884,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,21884,1,4,0)
 ;;=4^E16.2
